The company's shareholders elected Brian Windsor and Alan A. Musso as Class I directors, and Marcum LLP was ratified as the independent registered public accounting firm for the fiscal year ending ...

In March 2024, Brian Windsor, Ph.D., was appointed Chief Executive Officer of the Company, marking the Company's sole focus on advancing a pipeline of first-in-class therapies for orphan pulmonary ...

What should I know about this advisor? Brian Windsor is a financial advisor in McLean, VA, and have earned their CFP. They have been in practice for 14 years, the last 2 years at Bogart Wealth LLC.

Cash, cash equivalents, and investments on December 31, 2024, were $12.9M, compared to $17.3M on December 31, 2023. “We’ve made significant clinical progress during 2024, culminating in ...

AUSTIN, Texas, April 30, 2025 /PRNewswire/ -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant ...